Although the activating mutation of CTNNB1, the most frequent mutation in HCC, does not induce a tumor, the loss-of-APC or Axin1 mutation, both less common in HCC, are able to do so [40,41]. The gene discussed is AXIN1; the disease is hepatocellular carcinoma.